Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,657 | -19,358 | -11,436 | -7,284 | -2,745 |
| Depreciation Amortization | N/A | 2 | 2 | 2 | 1 |
| Accounts payable and accrued liabilities | -366 | 2,072 | -69 | 119 | -643 |
| Other Working Capital | -590 | 2,640 | 62 | 126 | -635 |
| Other Operating Activity | 1,910 | 4,732 | 4,701 | 2,969 | 2,187 |
| Operating Cash Flow | $-4,703 | $-9,914 | $-6,739 | $-4,068 | $-1,835 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,030 | 12,000 | 6,454 | 3,101 | 492 |
| Financing Cash Flow | $9,030 | $12,000 | $6,454 | $3,101 | $492 |
| Beginning Cash Position | 6,178 | 4,092 | 4,092 | 4,092 | 4,092 |
| End Cash Position | 10,505 | 6,178 | 3,807 | 3,125 | 2,750 |
| Net Cash Flow | $4,327 | $2,086 | $-285 | $-967 | $-1,342 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,703 | -9,914 | -6,739 | -4,068 | -1,835 |
| Free Cash Flow | -4,703 | -9,914 | -6,739 | -4,068 | -1,835 |